文献速递乳腺癌头颈与中枢神经肿瘤

乳腺癌脑转移列线图预测模型的构建与验证

[Construction and validation of a nomogram prediction model for brain metastasis in breast cancer].
PubMed 文献 · Zhonghua Zhong Liu Za Zhi · 2026-01-01

该研究基于新疆医科大学附属肿瘤医院346例乳腺癌患者和SEER数据库1483例女性乳腺癌患者,整合分子标志、影像特征及临床病理特征构建脑转移列线图预测模型。模型在训练集、内部验证集和外部验证集的AUC分别为0.869、0.857和0.868,校准曲线贴近参考线,阈值概率>0.2时净获益显著优于全干预或全不干预策略。

要点

  • 模型整合11个关键特征,包括病灶数量、组织学分级、分化程度、Ki-67指数、临床分期和脉管瘤栓等。
  • 训练集、内部验证集和外部验证集AUC分别为0.869、0.857和0.868,区分能力良好。
  • 阈值概率>0.2时净获益显著高于全干预或全不干预策略,具有临床适用性。

核心结论

  • 成功构建整合分子亚型、影像学特征及临床病理特征的乳腺癌脑转移列线图预测模型,区分能力良好且校准度和临床适用性较好。

研究设计与样本

  • 纳入2018年1月至2023年12月新疆医科大学附属肿瘤医院346例乳腺癌患者(脑转移组214例,对照组132例),按7∶3分为训练集242例和内部验证集104例。
  • 外部验证集为SEER数据库2017—2021年1483例女性乳腺癌患者(脑转移组530例,对照组953例)。
  • 采用LASSO回归筛选关键特征,基于多因素logistic回归构建列线图模型,用ROC曲线、校准曲线和决策曲线分析评估性能。

主要发现

  • LASSO回归筛选出11个关键特征:原发侧别、原发象限、病灶数量、组织学分级、分化程度、Ki-67指数、N分期、临床分期、脉管瘤栓、纵横比、病灶结构形态。
  • 多因素logistic回归显示多病灶OR=7.49(95%CI:3.59~15.64),组织学分级2级OR=9.02(95%CI:4.87~16.70)、3级OR=12.57(95%CI:6.60~23.94)。
  • 分化程度中分化OR=0.18(95%CI:0.06~0.53)、高分化OR=0.02(95%CI:0.01~0.06),Ki-67指数15%~29% OR=0.28(95%CI:0.11~0.74)、≥30% OR=4.01(95%CI:2.45~6.58)。
  • 临床分期Ⅲ期OR=3.53(95%CI:1.76~7.07)、Ⅳ期OR=35.43(95%CI:13.97~89.91),有脉管瘤栓OR=12.42(95%CI:6.84~22.53)。
  • 训练集、内部验证集和外部验证集AUC分别为0.869(95%CI:0.826~0.912)、0.857(95%CI:0.817~0.897)和0.868(95%CI:0.849~0.887),校准曲线均贴近参考线,阈值概率>0.2时净获益显著高于全干预或全不干预策略。

关键数值与推荐

  • 多病灶、组织学分级2级和3级、Ki-67指数≥30%、临床分期Ⅲ期和Ⅳ期、有脉管瘤栓为乳腺癌脑转移的独立危险因素。
  • 中分化和高分化、Ki-67指数15%~29%为保护性因素。
  • 模型预测乳腺癌脑转移的AUC在训练集为0.869(95%CI:0.826~0.912),内部验证集为0.857(95%CI:0.817~0.897),外部验证集为0.868(95%CI:0.849~0.887)。

临床怎么用

  • 该列线图模型可作为临床评估乳腺癌脑转移风险的量化工具,辅助精准分层。
  • 当阈值概率>0.2时模型净获益优于全干预或全不干预策略,可在此范围内用于临床决策参考。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To construct a prediction model integrating molecular markers, imaging features, and clinicopathological characteristics for brain metastasis (BM) of breast cancer and provide a quantitative tool for clinical precise stratification of breast cancer. Methods: A total of 346 breast cancer patients admitted to the Affiliated Tumor Hospital of Xinjiang Medical University from January 2018 to December 2023 were enrolled, including 214 cases in the BM group and 132 cases in the control group. The patients were divided into a training set (242 cases) and an internal validation set (104 cases) at a ratio of 7∶3. A total of 1,483 female breast cancer patients from the Surveillance, Epidemiology, and End Results Program (SEER) database (2017-2021) were used as the external validation set, including 530 cases in the BM group and 953 cases in the control group. Least Absolute Shrinkage and Selection Operator (LASSO) regression was used to screen key features, and a nomogram prediction model for breast cancer BM was constructed based on the results of multivariate logistic regression analysis of factors influencing breast cancer BM. The receiver operating characteristic (ROC) curve, calibration curve, and decision curve analysis (DCA) were used to evaluate the model performance, and internal and external validations of the model were conducted. Results: LASSO regression based on the training set screened out 11 key features, namely, primary side, primary quadrant, number of lesions, histological grade, differentiation degree, Ki-67 index, N stage, clinical stage, lymphovascular invasion, aspect ratio, and lesion margin morphology. Multivariate logistic regression analysis showed that the number of lesions (multiple lesions: OR=7.49, 95% CI: 3.59-15.64), histological grade (grade 2: OR=9.02, 95% CI: 4.87-16.70; grade 3: OR=12.57, 95% CI: 6.60-23.94), differentiation degree (moderate differentiation: OR=0.18, 95% CI: 0.06-0.53; well differentiation: OR=0.02, 95% CI: 0.01-0.06), Ki-67 index (15%-29%: OR=0.28, 95% CI: 0.11-0.74; ≥30%: OR=4.01, 95% CI: 2.45-6.58), clinical stage (stageⅢ: OR=3.53, 95% CI: 1.76-7.07; stage Ⅳ: OR=35.43, 95% CI: 13.97-89.91), and lymphovascular invasion (presence of lymphovascular invasion: OR=12.42, 95% CI: 6.84-22.53) were independent influencing factors for breast cancer BM. The nomogram prediction model for breast cancer BM constructed based on the results of multivariate logistic regression analysis had areas under the curve (AUCs) for predicting breast cancer BM of 0.869 (95% CI: 0.826-0.912), 0.857 (95% CI: 0.817-0.897), and 0.868 (95% CI: 0.849-0.887) in the training set, internal validation set, and external validation set, respectively. All calibration curves were close to the reference line, and when the threshold probability was >0.2, the net benefit was significantly higher than that of the "treat all" or "treat none" strategy. Conclusions: A nomogram prediction model for breast cancer BM integrating multi-dimensional information (molecular subtypes, imaging features, and clinicopathological characteristics) was successfully constructed. This model has good ability to distinguish breast cancer patients with BM from thosewithout, with favorable calibration and clinical applicability, and provides a quantitative tool for clinical assessment of the risk of breast cancer BM. 目的: 构建整合分子标志、影像学特征及临床病理特征的乳腺癌脑转移预测模型,为乳腺癌的临床精准分层提供量化工具。 方法: 纳入2018年1月至2023年12月新疆医科大学附属肿瘤医院收治的346例乳腺癌患者,其中脑转移组214例,对照组132例。按照7︰3的比例分为训练集(242例)和内部验证集(104例)。将监测、流行病学和结果(SEER)数据库中2017—2021年的1 483例女性乳腺癌患者作为外部验证集,其中脑转移组530例,对照组953例。采用最小绝对收缩与选择算子(LASSO)回归筛选关键特征,并基于乳腺癌脑转移影响因素的多因素logistic回归分析结果构建乳腺癌脑转移列线图预测模型。采用受试者操作特征曲线、校准曲线及决策曲线分析评估模型性能,并对模型进行内部和外部验证。 结果: 基于训练集的LASSO回归筛选出11个关键特征,分别为原发侧别、原发象限、病灶数量、组织学分级、分化程度、Ki-67指数、N分期、临床分期、脉管瘤栓、纵横比、病灶结构形态。多因素logistic回归分析显示,病灶数量(多病灶:OR=7.49,95% CI:3.59~15.64)、组织学分级(2级:OR=9.02,95% CI:4.87~16.70;3级:OR=12.57,95% CI:6.60~23.94)、分化程度(中分化:OR=0.18,95% CI:0.06~0.53;高分化:OR=0.02,95% CI:0.01~0.06)、Ki-67指数(15%~29%:OR=0.28,95% CI:0.11~0.74;≥30%:OR=4.01,95% CI:2.45~6.58)、临床分期(Ⅲ期:OR=3.53,95% CI:1.76~7.07;Ⅳ期:OR=35.43,95% CI:13.97~89.91)和脉管瘤栓(有脉管瘤栓:OR=12.42,95% CI:6.84~22.53)是乳腺癌脑转移的独立影响因素。基于多因素logistic回归分析结果构建的乳腺癌脑转移列线图预测模型,在训练集、内部验证集和外部验证集预测乳腺癌脑转移的曲线下面积分别为0.869(95% CI:0.826~0.912)、0.857(95% CI:0.817~0.897)和0.868(95% CI:0.849~0.887),校准曲线均贴近参考线,当阈值概率>0.2时的净获益均显著高于“全干预”或“全不干预”策略。 结论: 成功构建了整合分子亚型、影像学特征及临床病理特征等多维度信息的乳腺癌脑转移列线图预测模型,该模型对乳腺癌脑转移与非脑转移患者的区分能力良好,具有较好的校准度和临床适用性,为临床评估乳腺癌脑转移的风险提供了量化工具。.

来源:Zhonghua Zhong Liu Za Zhi,查看原文。版权归原作者所有。

引用

  1. Tuerxunjiang G, Wang YH, Wu D, et al. [Construction and validation of a nomogram prediction model for brain metastasis in breast cancer]. Zhonghua Zhong Liu Za Zhi. 2026. PMID: 42151088. doi:10.3760/cma.j.cn112152-20250309-00098

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。